February 3, 2025 02:16 PM ESTUpdated 03:21 PM
People
Health Tech

Ex­clu­sive: Noom cuts coach­es and cus­tomer ser­vice staff as GLP-1 strat­e­gy falls short

Ngai Yeung

Health Tech Reporter

Noom has laid off em­ploy­ees in coach­ing and cus­tomer ser­vice af­ter its bet on pre­scrib­ing GLP-1 drugs didn’t grow as much as it ex­pect­ed, …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Drug­mak­ers seize on bio­mark­ers to test the FDA's rare dis­ease shift

Bio­gen’s re­vised re­search strat­e­gy is to avoid be­com­ing ob­so­lete, top ex­ec says

Up­dat­ed: Drug prices like­ly to soar due to Trump tar­iffs, phar­ma bod­ies warn

Ex­clu­sive: Ger­man biotech de­clares Phase 2 win for non-opi­oid drug for neu­ro­path­ic pain

Irish start­up re­ports mid-stage vic­to­ry for short-act­ing psy­che­del­ic drug in de­pres­sion

Sen­ate De­moc­rats say RFK Jr.'s di­vest­ment plans are 'plain­ly in­ad­e­quate' ahead of Tues­day vote

A service from the Financial Times